FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
FENNEC PHARMACEUTICALS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$10.27+0.29 (+2.91%)
Close on Oct 19, 2026
- Market cap
- $374.14M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Fennec Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 17, 2026 | Sep 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 10, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 18, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 27, 2026 | Apr 28, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2026 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 22, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2026 | Apr 7, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2026 | Mar 24, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2026 | Mar 4, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2026 | Feb 20, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2025 | Dec 9, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2025 | Dec 2, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 19, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 17, 2025 | Nov 18, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2025 | Jun 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 3, 2025 | Apr 25, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 26, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 7, 2025 | Feb 7, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 20, 2024 | Dec 20, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2024 | Dec 20, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 8, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 28, 2024 | Oct 30, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2024 | Jul 2, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2024 | Jun 25, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 25, 2024 | May 13, 2024 | SEC EDGAR |
| Current report | 8-K | May 7, 2024 | May 9, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 29, 2024 | SEC EDGAR |